Journal of Hepatocellular Carcinoma
Volume 11, 2024 - Issue
Open access
37
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH
A Novel Nomogram to Predict Prognosis of Advanced Hepatocellular Carcinoma Treated with Intensity-Modulated Radiotherapy Plus Anti-PD1
Meiling He1 Department of Radiation Oncology, Guangxi Medical University Cancer Hospital, Nanning, 530021, People’s Republic of ChinaView further author information
, Chunfeng Liang1 Department of Radiation Oncology, Guangxi Medical University Cancer Hospital, Nanning, 530021, People’s Republic of ChinaView further author information
, Yadan Pang1 Department of Radiation Oncology, Guangxi Medical University Cancer Hospital, Nanning, 530021, People’s Republic of ChinaView further author information
, Mengjie Jiang1 Department of Radiation Oncology, Guangxi Medical University Cancer Hospital, Nanning, 530021, People’s Republic of ChinaView further author information
, Meiying Long2 School of Public Health, Guangxi Medical University, Nanning, 530021, People’s Republic of ChinaView further author information
, Zhongqiang Yao3 Department of General Affairs, Guangxi Medical University Cancer Hospital, Nanning, 530021, People’s Republic of ChinaView further author information
, Xiaoting Wang1 Department of Radiation Oncology, Guangxi Medical University Cancer Hospital, Nanning, 530021, People’s Republic of ChinaView further author information
, Ruijun Zhang1 Department of Radiation Oncology, Guangxi Medical University Cancer Hospital, Nanning, 530021, People’s Republic of ChinaView further author information
, Qiaoyuan Wu1 Department of Radiation Oncology, Guangxi Medical University Cancer Hospital, Nanning, 530021, People’s Republic of ChinaView further author information
, Shixiong Liang1 Department of Radiation Oncology, Guangxi Medical University Cancer Hospital, Nanning, 530021, People’s Republic of ChinaCorrespondence[email protected] [email protected]
View further author information
& View further author information
Jianxu Li1 Department of Radiation Oncology, Guangxi Medical University Cancer Hospital, Nanning, 530021, People’s Republic of ChinaView further author information
show all
Pages 913-925
|
Received 24 Feb 2024, Accepted 07 May 2024, Published online: 23 May 2024
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.